Literature DB >> 27712631

Role of Neuroinflammation in Parkinson Disease: The Enigma Continues.

Shyamal H Mehta1, Caroline M Tanner2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27712631     DOI： 10.1016/j.mayocp.2016.08.010

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  5 in total

1.  Microglial autophagy defect causes parkinson disease-like symptoms by accelerating inflammasome activation in mice.

Authors:  Jinbo Cheng; Yajin Liao; Yuan Dong; Han Hu; Nannan Yang; Xiangxi Kong; Shuoshuo Li; Xiaoheng Li; Jifeng Guo; Lixia Qin; Jiezhong Yu; Cungen Ma; Jianke Li; Mingtao Li; Beisha Tang; Zengqiang Yuan
Journal:  Autophagy       Date:  2020-01-31       Impact factor: 16.016

2.  Neuroprotective Effects of Temsirolimus in Animal Models of Parkinson's Disease.

Authors:  Rosalba Siracusa; Irene Paterniti; Marika Cordaro; Rosalia Crupi; Giuseppe Bruschetta; Michela Campolo; Salvatore Cuzzocrea; Emanuela Esposito
Journal:  Mol Neurobiol       Date:  2017-03-29       Impact factor: 5.590

3.  A Case-Control Association Study of RANTES (-28C>G) Polymorphism as a Risk Factor for Parkinson's Disease in Isparta, Turkey.

Authors:  Nilufer Sahin-Calapoglu; Serpil Demirci; Mustafa Calapoglu; Baris Yasar
Journal:  Parkinsons Dis       Date:  2016-12-18

4.  Therapeutic Role of Protein Tyrosine Phosphatase 1B in Parkinson's Disease via Antineuroinflammation and Neuroprotection In Vitro and In Vivo.

Authors:  Chien-Wei Feng; Nan-Fu Chen; Te-Fu Chan; Wu-Fu Chen
Journal:  Parkinsons Dis       Date:  2020-12-29

5.  Parkinsonism Attenuation by Antihistamines via Downregulating the Oxidative Stress, Histamine, and Inflammation.

Authors:  Maira Ayaz; Fareeha Anwar; Uzma Saleem; Irum Shahzadi; Bashir Ahmad; Ali Mir; Tariq Ismail
Journal:  ACS Omega       Date:  2022-04-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.